Esophageal Squamous Cell Carcinoma (ESCC) Clinical Trials
2 recruiting trials for Esophageal Squamous Cell Carcinoma (ESCC). Eligibility criteria explained in plain English.
2
Total Trials
2
Recruiting Now
0
Phase 3 Trials
2
Sponsors
Recruiting Trials
RECRUITINGPhase 1NCT07317609
Neoadjuvant Immunotherapy Combined With Chemotherapy Sequenced With Endoscopic Resection for Esophageal Cancer...
This single-center, prospective, single-arm study will evaluate whether giving neoadjuvant chemoimmunotherapy can safely shrink esophageal cancer and allow organ-preserving...
Sponsor: Shanghai Zhongshan HospitalEnrolling: 601 location
RECRUITINGPhase 2NCT07039162
Study of Tislelizumab Combined With Chemoradiotherapy and Surgery for Unresectable Esophageal Squamous Cell Carcinoma
This is a Phase II, open-label, single-arm, multicenter study evaluating the safety and efficacy of combining Tislelizumab with induction chemoradiotherapy (CRT), followed by...
Sponsor: Ming-Yu LienEnrolling: 458 locations